http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021130657-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9fa13c33b79ba86e25d61d5e3cee4f2 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498 |
| filingDate | 2021-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cc426d1543f36209ca4f6ef9b1c5e57 |
| publicationDate | 2021-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2021130657-A |
| titleOfInvention | Pharmaceutical products |
| abstract | PROBLEM TO BE SOLVED: To provide an aqueous solution containing chlorous acid and / or a salt thereof, and boric acid and / or a salt thereof, and to suppress a decrease in the content of chlorous acid and / or a salt thereof. To provide technology related to products. A pharmaceutical product comprising an aqueous solution containing chlorous acid and / or a salt thereof, boric acid and / or a salt thereof, and brimonidine and / or a salt thereof contained in a gas-sterilized container. .. [Selection diagram] None |
| priorityDate | 2020-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 103.